Reforms related to the 340B program and the pharmaceutical supply chain. Opposed the International Pricing Index model (83 FR 54546). Medicare Parts B and D reform. Home administration of injectable and infusible drugs including in CMS-1744-IFC and CMS-5531-IFC, as well as H.R. 6218/ S. 3457, the Preserving Patient Access to Home Infusion Act.
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
JOHN MCMANUS ALANNA TEMME JOHN MCMANUS ALANNA TEMME